What Does Molly Look Like: Forms, Colours & What to Know
Maybe you've got some white crystals and want to know whether there's MDMA inside. Or maybe you're simply curious about what real MDMA looks like.
Either way, search "what does molly look like" and most results will give the same flat answer: white powder or crystals. In reality, molly can appear as powder, crystals, pressed pills or capsules, in colours ranging from white through to brown, blue and purple.
In this guide we draw on our own real-world drug-checking data to show you what real-life molly looks like. Keep reading to learn the different forms and colours molly takes, why appearance tells you almost nothing about what's inside, and how to reduce risk with practical at-home drug testing kits.
Author: Elisa Doro-Goldsmith, MChem - Reviewer: Dr. Felix Blei (Scientific head of the german drugchecking projekt ALIVE)
Published: 2nd April 2026
Updated: 18th September 2026
Reading time: ~ 6 min
🔎 What is Molly and What Does it Look Like?
Molly (also Ecstasy, XTC or E) is a common street name for MDMA (3,4-methylenedioxymethamphetamine), a synthetic drug with stimulant and empathogenic effects. While "Molly" is often associated with powder or crystalline MDMA, the term is also used more broadly for any MDMA-containing product, including pills and capsules.
Unlike a standardised pharmaceutical product, molly doesn't have one fixed look. As an illicit drug, it is produced and sold outside regulated manufacturing systems, meaning that production methods, moisture content, adulterants and fillers can all change its appearance.
The result? Molly can look remarkably different from one sample to the next, meaning that looks alone can't tell you anything about MDMA contents, purity or potency.
Appearance
What Does Real Molly Look Like?
Many people assume that "real" or pure MDMA should appear as bright white solid crystals and this expectation can also be exploited to make a sample appear "cleaner" or “purer” than it really is. Fillers can be added to increase bulk or alter the appearance of MDMA crystals, creating a whiter, more uniform-looking product.
But here's the catch: white doesn't mean pure and white doesn't mean MDMA. Countless drugs including MDMA, cocaine, ketamine and heroine can all appear as white crystals or powders, so even knowing what "pure" molly looks doesn't help when other substances look identical.
The shape of a crystal also doesn't help, with the texture, form and hardness differing based on water content, drying process and starting materials rather than the final active ingredient.
Our own drug-checking results demonstrate this clearly. The whitest and "cleanest-looking" MDMA crystals we analysed had the lowest purity at 73%, while samples with 96% and 100% purity were noticeably more yellow and of a softer consistency.
White MDMA Crystals: 73% Purity
Yellow MDMA Crystals: 96% Purity
Yellow MDMA Crystals: 100% Purity
molly forms
Molly Forms: Powder, Crystals, Pills & Capsules
Molly (MDMA, Ecstasy) can take many forms and colours. You may come across fine powder, chunky crystals, brightly coloured pills or capsules, with colours ranging from white and clear to brown, blue and purple.
Below are some real-world MDMA samples analysed through our drug-checking work, alongside what each form typically looks like, how common it is and the assumptions often made about it.
| Form | Appearance | Common Myths |
| Powder | Fine or coarse; often white or off-white, but also yellow, brown, grey or other colours | White powder is purer than coloured powder |
| Crystal | Flakes, shards or irregular fragments; can be clear, white, brown, blue, purple or other colours | Crystals are purer or stronger than other forms |
| Pressed Pills | Brightly coloured tablets in many shapes, often stamped with logos, symbols or patterns | The same logo or appearance mean a known or consistent dose |
| Capsules | Clear or coloured capsules containing powder or crystals | Capsules contain a measured or consistent product |
Our drug-checking results show just how misleading these myths can be. That’s why drug-checking tools such as the MDMA QTest® can provide valuable information when you want to know what’s actually in your sample.
Pressed Pills
Appearance: Brightly coloured tablets in different shapes and sizes, often stamped with logos, symbols or patterns
Misconception: Identical-looking pills contain the same amount of MDMA
Reality: Pills that look the same can contain very different MDMA contents
Powder
Appearance: Fine or slightly coarse powder, ranging from white and off-white to yellow, grey, beige or brown
Misoconception: White powder is purer than coloured powder
Reality: Colour and texture aren't a reliable purity marker due to production methods
Crystal
Appearance: Flakes or shards, ranging from fine, powder-like pieces to larger, slightly shiny crystals
Misconception: Large, clear crystals are purer or stronger than powder
Reality: Drug-checking has found both unadulterated and adulterated crystal samples
Capsules
Appearance: Clear or coloured capsules containing powder or small crystals
Misconception: Contents have been carefully measured or are more consistent
Reality: The capsule is simply a form of presentation and doesn't ensure consistency
Why Appearance Can Be Misleading: Four Lab-Tested Samples
Four identical pills, four very different MDMA contents.
We analysed four blue Punisher pills with the same colour, shape and stamp in our lab. Despite looking almost identical, they contained 80 mg, 198 mg, 207 mg and 263 mg of MDMA respectively.
That means the strongest pill contained more than three times as much MDMA as the weakest, with no obvious visual difference between them.
Why can this happen?
MDMA is produced outside standardised manufacturing systems, so differences in production, processing, mixing and tablet pressing can result in very different amounts of MDMA between pills. Uneven mixing or inconsistent production can mean that even pills made from the same source don't necessarily contain the same dose.
Want to see more real-world drug-checking results? Explore our drug-checking data here
MDMA QTest®: Determine Molly Purity yourself at Home
So if appearance can be deceiving, how can you find out what's actually in your sample?
Fortunately, you don't have to rely on looks or guesswork. The MDMA QTest® by miraculix is a quantitative at-home test that lets you test pills, powder and crystals for MDMA and determine their potency — with results in under 15 minutes.
With the MDMA QTest®, you can:
- Confirm whether your sample contains MDMA
- Measure MDMA concentration in mg or %
- Detect MDA, 2C-B, amphetamine and other adulterants
Using just 30–50 mg of sample, the test produces a clear colour result that indicates the MDMA concentration.
For additional screening, you can also combine it with the Synthetic Cathinones Detection Kitto rule out other common adulterants such as 3-MMC and eutylone.
Learn more about the MDMA QTest® here.
fake molly
Real-World Case Studies: What Does Fake Molly Look Like?
Our drug-checking analyses with the ALIVE project have also uncovered instances of "fake molly": samples sold as MDMA that contained little or no MDMA at all. Even pressed pills, which are strongly associated with MDMA, can contain an entirely different substance.
These substances are sometimes referred to as adulterants or substitutes and are often used because they are cheaper than or more readily available than MDMA, or to intentionally alter effects. Common examples include 2C-B, amphetamines, PMA/PMMA, synthetic cathinones, ketamine and other new psychoactive substances.
Below are three examples of pills and crystals that were mis-sold as or mistaken for MDMA:
Green "Ecstasy" Pill: 2C-B Mis-sold as MDMA
We tested this green pressed pill sold as MDMA but found to contain 2C-B instead. As a psychedelic, 2C-B produces effects that differ significantly from MDMA, including altered perception, visual effects and changes in thinking. Taking it unexpectedly can therefore be particularly difficult to navigate.
White Crystals = Molly? Ketamine instead of MDMA
These fine white crystals could easily be mistaken for MDMA, but testing showed that they actually contain ketamine. This illustrates a particularly important point for anyone asking what “crystal Molly” should look like: different substances can look remarkably similar, while the same substance can also vary significantly.
Blue Punisher Pill: Caffeine and Amphetamine
In June 2026, Berlin Drug Checking reported a blue Punisher pill sold as MDMA that contained caffeine and amphetamine, with no MDMA detected. The recognisable, "classic" logo and blue colour for ecstasy pills did not reveal its actual contents.
molly colour
What Colour is Molly? Brown, Blue and Purple MDMA
Now that we've established its various forms, what colour is Molly? Brown, blue, purple and white MDMA can all be found in the real world.
Bright colours are mostly associated with pressed pills, while powders and crystals are more commonly white, off-white, grey or yellow — although coloured samples exist in these forms too. Differences in colour can come from:
- Dyes (deliberately added to create a distinctive appearance, particularly in pressed pills)
- Fillers (ingredients added to help increase bulk or make a sample appear lighter/brighter)
- Adulterants (other psychoactive substances or contaminants)
Below are three examples of molly samples in a range of colours, all encountered in our drug checking analyses:
Dark Brown MDMA Crystals: 80% Purity
Light Beige MDMA Crystals: 83% Purity
Bright White MDMA Crystals: 90% Purity
Final Thoughts: What Molly Really Looks Like
Molly doesn't have one standard appearance: it can be powder, crystals, pills or capsules, in colours ranging from white and clear to brown, blue and purple. And as our drug-checking results show, the same form can vary in potency, unusual colours don't necessarily mean lower purity, and even pills with identical logos and appearances can contain dramatically different amounts of MDMA.
The instinct to judge a substance by how it looks is completely natural, but in the case of MDMA, it can be genuinely dangerous. When you can't tell what's inside, chemical testing provides information that appearance simply can't. Tools such as the MDMA QTest®make this kind of testing accessible, allowing you to replace assumptions with data before use.
Remember:
- White crystals or powder don't automatically mean higher purity
- Familiar colours, shapes and logos don't mean a consistent dose
- Something sold as Molly might not contain any MDMA
The bottom line? When the stakes are high, knowing what a sample actually contains is far more useful than knowing what it "should" look like.
explore more
Explore More: Purple Molly, At-Home Testing & MDMA Appearance
If you're looking to reduce risk and deepen your understanding of MDMA, check out the miraculix MDMA Hub. Here we bring together our most trusted, evidence-based resources to help you stay informed. Here are just a few expert-backed guides you might find useful:
Purple Molly: Why it's Purple & Whether it's Safe
Purple molly is not a purer form of MDMA, a different compound or a quality signal. It's a colour that tells you nothing about what's actually inside. Here's what the evidence says about purple molly.
How to Test MDMA: A Step-by-Step Guide
Reagent kits can flag dangerous adulterants. The MDMA QTest® can tell you how much MDMA is actually there. Discover how to use both, what the results mean and why testing is one of the most important steps in harm reduction.
MDMA Overdose Guide: Signs & Safer Choices
An MDMA overdose can happen to experienced users and first-timers alike. Learn how to recognise early warning signs, understand what drives toxicity beyond dose and know exactly what to do when it matters most.
Frequently Asked Questions: What Does Molly Look Like
Still wondering what molly looks like in real life? Below are answers to the most common questions about molly's appearance, forms and colours along with what appearance can and cannot tell you about purity and safety.
Molly most commonly appears as white or off-white powder, crystals or pressed pills, though it can also come in gel capsules. Colour ranges from white to grey, yellow, brown or purple. Appearance varies widely between batches and sources and cannot tell you what a substance actually contains.
Molly can be white, off-white, grey, yellow, brown or purple. Colour is determined by how it was synthesised, what adulterants are present and how it has been processed or stored. There is no single correct colour for MDMA and a white appearance does not mean a substance is purer or safer.
MDMA in powder or crystal form often has a faint chemical or slightly anise-like smell though this varies significantly between batches. Pressed pills may have little to no detectable odour. Smell is not a reliable indicator of content or purity and should never be used to identify a substance.
Molly comes in four main forms: powder, crystals, pressed pills and gel capsules. Powder ranges from fine and flour-like to slightly coarse. Crystals appear as shards or flakes. Pills are often brightly coloured and stamped with logos. Capsules contain powder or crystals inside a clear or coloured gel casing.
No. Colour and form are unreliable indicators of purity, quality or safety. A white powder can be heavily adulterated while a brown crystal can be relatively pure MDMA. The only way to have any confidence in what a substance contains is to test it using a drug checking tool.
Purple molly usually refers to MDMA crystals or powder that appear purple, pinkish-purple or have a darker colour. The colour can come from impurities, dyes or other substances and does not confirm that the product contains MDMA.
Brown molly can contain MDMA, but its colour cannot confirm that. MDMA crystals and powders can vary in appearance, and brown colouring may also come from impurities, dyes or other substances. As shown in our drug-checking data, a brown molly sample can be higher purity than a white molly sample, but this should not be assumed on appearance alone.
Not necessarily. Crystals are often marketed as a purer form of MDMA but adulterants are just as commonly found in crystals as in powder. The form a substance takes reflects how it was processed not what it contains. Testing is the only way to assess what is actually present.
Molly is produced in unregulated illegal settings with no standardised process or quality control. Differences in synthesis methods, raw materials and adulterants all affect the final appearance. The MDMA market also shifts constantly as supply chains evolve meaning colour, texture and form can vary significantly between batches and regions.
Fake molly can look identical to MDMA. Substances like synthetic cathinones are often sold as molly and are visually indistinguishable. Appearance cannot confirm whether a substance is real MDMA. Drug checking tools such as the MDMA QTest® are the only reliable way to identify what a substance actually contains.
Common adulterants found in molly include synthetic cathinones such as methylone and mephedrone, other stimulants, caffeine and research chemicals. In some cases pills sold as molly contain no MDMA at all. Adulterants can be present in any form including powder, crystals and pressed pills regardless of appearance.
Not necessarily. “Blue Molly” and “regular Molly” are informal terms that may describe how a sample looks rather than a different form of MDMA. MDMA can appear in different colours and textures, but colour alone does not show whether a sample contains MDMA, how pure it is or how strong it may be. Testing is needed to find out what is actually in a sample.
No. Logos, colours and shapes on pressed pills are purely cosmetic and give no indication of dose or content. Pills with identical branding can vary significantly in strength and composition between batches. High dose pills have become increasingly common and a familiar-looking pill may be far stronger than expected.
Pill strength varies enormously. A typical pill might contain anywhere from 80 mg to well over 200 mg of MDMA though this cannot be determined by appearance. Miraculix Lab has identified pills containing 214 mg in real-world drug checking. Testing before use and starting with a low dose is strongly advised.
No. Experienced users cannot reliably identify MDMA by sight, smell or taste. While familiarity with certain forms may feel reassuring it provides no meaningful information about content or strength. Substances that look or feel familiar can differ significantly in composition between batches. Testing is the only way to reduce this uncertainty.
The MDMA QTest® allows you to test molly at home in under 15 minutes. It can detect the presence of MDMA and common adulterants and estimate the strength of the sample. No home test eliminates all risk but testing significantly reduces uncertainty and supports safer decision making compared to relying on appearance alone.
You can explore the miraculix MDMA Hub, which brings together trusted, expert-reviewed guides on the chemistry of molly, its short- and long-term effects, and practical harm reduction advice. It also includes detailed information on at-home testing and how to interpret your results with the MDMA QTest®.
References
- National Institute on Drug Abuse, MDMA (Ecstasy/Molly), https://nida.nih.gov/research-topics/mdma-ecstasy-molly (accessed April 2026).
- European Union Drugs Agency, MDMA (Ecstasy) Drug Profile, https://www.euda.europa.eu/publications/drug-profiles/mdma_en (accessed April 2026).
- E. L. Sevigny, S. Thyssen, E. Erowid, R. Lea, Drug Alcohol Depend. 2024, 264, 112467. https://doi.org/10.1016/j.drugalcdep.2024.112467
- H. A. Naqi, S. M. Husbands, I. S. Blagbrough, Anal. Methods 2019, 11, 4795–4807. https://doi.org/10.1039/C9AY01403A
- S. Saleemi, S. J. Pennybaker, M. Wooldridge, M. W. Johnson, J. Psychopharmacol. 2017, 31, 1056–1060. https://doi.org/10.1177/0269881117715596
- L. Couchman, A. Frinculescu, C. Sobreira, T. Shine, J. Ramsey, M. Hecht, K. Kipper, D. Holt, A. Johnston, Drug Test. Anal. 2019. https://doi.org/10.1002/dta.2605
- H. Valente, D. Martins, H. Carvalho, C. V. Pires, M. C. Carvalho, M. Pinto, M. J. Barratt, Int. J. Drug Policy 2019, 73, 88–95. https://doi.org/10.1016/j.drugpo.2019.07.007
Disclaimer
This article is aimed to inform and to educate. It does not encourage the consumption, possession or distribution of MDMA in any form. Here at miraculix, we support safer, more informed decisions and wish to empower individuals to take control of their own wellbeing.
You can read more about our mission and ongoing projects here.
N.B. We are not a public health authority. Key references are provided throughout this blog post and all sources used are provided below in the references section. Readers are encouraged to always refer to public health sources for up-to-date and additional guidance.
Substance testing — whether using reagent kits or the MDMA QTest® — cannot guarantee safety. These tools help identify red flags and reduce risks, but no test can confirm that a substance is entirely safe or pure. Always interpret results with caution and seek expert advice when needed.
Miraculix does not assume liability for any actions taken based on the use or interpretation of our products or content. Always follow your local laws and regulations.
about the author
Elisa Doro-Goldsmith - Scientific Author
Elisa Doro-Goldsmith, MChem (Hons), is a recent chemistry graduate from the University of Edinburgh with a strong foundation in analytical chemistry and a growing passion for harm reduction and science communication. Her master’s research, conducted in collaboration with the Technische Universität Berlin, focused on anisotropic NMR spectroscopy and her findings were successfully published in the Journal of Natural Products, where she co-authored a paper on the absolute configuration of a novel natural product with antiviral properties.
Motivated by a commitment to harm reduction and safety awareness around recreational drug use, Elisa joined miraculix, where she contributes towards accessible, evidence-based content that supports safer practices in nightlife. In her free time, she works as part of the safety awareness team at a Berlin-based electronic music collective, where she engages directly in harm-reduction and education.
You can learn more about her professional background on LinkedIn.
Elisa Doro-Goldsmith, MChem (Hons)
Reviewer PROFILE
Dr. Felix Blei – Scientific Author
Dr. Felix Blei is the CEO and Founder of miraculix Lab, and a Postdoctoral Researcher at the Friedrich Schiller University Jena. With a PhD (Dr. rer. nat.) in Microbiology and a strong background in natural product biosynthesis, he is internationally recognized for his pioneering work on psychoactive fungi—particularly the biosynthesis of psilocybin and related compounds (Blei, F., 2020).
During his doctoral research at the Institute of Pharmaceutical Microbiology under Prof. Dirk Hoffmeister, Dr. Blei was the first to elucidate the full biosynthetic pathway of psilocybin in Psilocybe mushrooms (Fricke, Blei et al., 2017) Angewandte Chemie. He further developed an in vitro system capable of producing psilocybin, serotonin, and novel non-natural analogues (Blei et al., 2018) Chemistry- A European Journal . His discovery of naturally occurring β-carbolines in Psilocybe—compounds that may synergistically enhance psilocybin's neurotropic effects—led to the concept of “psilohuasca,” a naturally occurring combination of MAO inhibitors and psychedelics in fungi (Blei, Dörner et al. 2020) Chemistry–A European Journal.
Building on his academic expertise, Dr. Blei developed the first reliable rapid tests for psilocybin, which laid the foundation for the spin-off company miraculix. Today, miraculix provides quantitative drug checking tools that are used throughout Germany and Europe. He also leads the German ALIVE project—an evidence-based drug checking Initiative funded by state governments, offering mobile substance analysis and harm reduction at music festivals and public events.
With over 500 citations, numerous publications in high-impact journals, and a passion for accessible science, Dr. Blei bridges cutting-edge research with real-world application. His work contributes to safer substance use, public health strategies, and a deeper understanding of natural psychoactive compounds.
You can learn more about him on LinkedIn or read his publications on Researchgate
